Medtronic Acquires Klue to Bolster its Personalized Closed Loop Technology for Diabetes Management

 Medtronic Acquires Klue to Bolster its Personalized Closed Loop Technology for Diabetes Management

Medtronic Acquires Klue to Bolster its Personalized Closed Loop Technology for Diabetes Management

Shots:

  • Medtronic acquired Klue to incorporate its technology into Medtronic’s Personalized Closed Loop (PCL) insulin pump system to transform diabetes management. Medtronic will leverage Klue’s technology to enhance its market analytics and CGM technology to aid people utilizing MDI for avoiding high/ low glucose events
  • Klue’s technology utilizes activity trackers and analytics technology in conjunction with AI software to detect when a user is eating a meal and provide real-time insights into eating behaviors
  • Medtronic’s PCL system is designed for automatic insulin delivery and has received the FDA’s BT designation in Feb’2019. Additionally, Medtronic has acquired Nutrino Health, both the acquisitions strengthen its capabilities in integration of AI into diabetes management systems

Click here to­ read full press release/ article | Ref: Medtronic | Image: Klue

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post